Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
GPCR
#725
Structure Therapeutics Inc. American Depositary Shares
62.980
0
-0.54%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-0.54%
Monatliche Änderung
-29.15%
6 month change
+135.53%
Jahresänderung
+135.53%
Vorheriger Schlusskurs
63.325
0
Open
62.950
0
Bid
Ask
Low
62.950
0
High
62.980
0
Volumen
46
Märkte
Aktien
Gesundheitswesen
GPCR
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2023
2024
2025
Total assets
482.02 M
903.33 M
1.58 B
Total liabilities
29.05 M
38.49 M
67.54 M
Total equity
452.97 M
864.84 M
1.52 B
Total liabilities & shareholders' equities
482.02 M
903.33 M
1.58 B
Total debt
—
—
—
Net debt
—
—
—
Nachrichten
Structure Therapeutics: Cantor sieht Kurspotenzial durch neue Studiendaten
Structure Therapeutics shares could rise on obesity drug data, Cantor says
Structure Therapeutics: Citizens senkt Kursziel trotz vielversprechender Pipeline-Erweiterung
Citizens cuts Structure Therapeutics stock price target on pipeline expansion
Lilly's GLP-1 Blockbusters Drive 2025 Revenue Surge: What's Ahead?
Lilly vs. Novo Nordisk: Obesity Drug Giants' Face-Off in 2026
Novo Nordisk Dives As Next-Gen Obesity Drug Lags Eli Lilly's Kingpin
Structure Therapeutics: The Dark Horse Has Taken The Lead - But Is It Enough? (GPCR)
Can LLY's Next-Gen Obesity Pipeline Sustain Growth Amid Competition?
How to Play Eli Lilly Stock Following a Robust Q4 Earnings Report
Eli Lilly's 2025 Surge Sets the Stage for Another Big Year in 2026
Hims & Hers Health Stops Offering Knockoff Wegovy Pill Amid FDA Crackdown